cox 189 has been researched along with bupropion in 2 studies
Studies (cox 189) | Trials (cox 189) | Recent Studies (post-2010) (cox 189) | Studies (bupropion) | Trials (bupropion) | Recent Studies (post-2010) (bupropion) |
---|---|---|---|---|---|
163 | 49 | 47 | 3,392 | 755 | 1,329 |
Protein | Taxonomy | cox 189 (IC50) | bupropion (IC50) |
---|---|---|---|
Acetylcholine receptor subunit alpha | Homo sapiens (human) | 5.2693 | |
Acetylcholine receptor subunit gamma | Homo sapiens (human) | 5.2693 | |
Integrin alpha-5 | Homo sapiens (human) | 1.8 | |
Acetylcholine receptor subunit beta | Homo sapiens (human) | 5.2693 | |
Neuronal acetylcholine receptor subunit beta-2 | Homo sapiens (human) | 0.9373 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.2003 | |
Neuronal acetylcholine receptor subunit beta-4 | Homo sapiens (human) | 1.2028 | |
Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens (human) | 1.367 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 1.9983 | |
Neuronal acetylcholine receptor subunit alpha-7 | Homo sapiens (human) | 7.9 | |
Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens (human) | 0.0135 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.0848 | |
Acetylcholine receptor subunit delta | Homo sapiens (human) | 5.2693 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for cox 189 and bupropion
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for cox 189 and bupropion
Article | Year |
---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |